Skip to content

ACADIA PHARMACEUTICALS INC.: filings

Every ACADIA PHARMACEUTICALS INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 61 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-05fiscal Q2 2026471300001193125-26-333243
10-Q2026-05-07fiscal Q1 202646960001193125-26-209731
10-K2026-02-26fiscal FY 2025531380001193125-26-072519
10-Q2025-11-06fiscal Q3 2025461280001193125-25-267453
10-Q2025-08-07fiscal Q2 2025461280000950170-25-104295
10-Q2025-05-08fiscal Q1 202545940000950170-25-066231
10-K2025-02-27fiscal FY 2024521350000950170-25-029253
10-Q2024-11-07fiscal Q3 2024461280000950170-24-122513
10-Q2024-08-07fiscal Q2 2024451260000950170-24-092163
10-Q2024-05-09fiscal Q1 202445940000950170-24-056077
10-K2024-02-28fiscal FY 2023531760000950170-24-021473
10-Q2023-11-03fiscal Q3 2023451240000950170-23-058436
10-Q2023-08-03fiscal Q2 2023441220000950170-23-037458
10-Q2023-05-08fiscal Q1 202343900000950170-23-018927
10-K2023-02-28fiscal FY 2022521710000950170-23-004757
10-Q2022-11-03fiscal Q3 2022441220000950170-22-021438
10-Q2022-08-09fiscal Q2 2022441220000950170-22-015642
10-Q2022-05-05fiscal Q1 202240840000950170-22-007468
10-K2022-03-01fiscal FY 2021481450000950170-22-002392
10-Q2021-11-09fiscal Q3 2021411080001564590-21-055347
10-Q2021-08-05fiscal Q2 2021421100001564590-21-040986
10-Q2021-05-06fiscal Q1 202142860001564590-21-024268
10-K2021-02-25fiscal FY 2020481450001564590-21-008372
10-Q2020-11-04fiscal Q3 2020421120001564590-20-050566
10-Q2020-08-06fiscal Q2 2020421150001564590-20-036993
10-Q2020-05-08fiscal Q1 202041880001564590-20-023050
10-K2020-02-27fiscal FY 2019481450001564590-20-006889
10-Q2019-10-31fiscal Q3 2019421130001564590-19-038856
10-Q2019-08-01fiscal Q2 2019411080001564590-19-027565
10-Q2019-05-02fiscal Q1 201941850001564590-19-014909
10-K2019-02-27fiscal FY 2018431360001564590-19-004596
10-Q2018-11-06fiscal Q3 201837950001564590-18-027431
10-Q2018-08-08fiscal Q2 201837950001564590-18-020524
10-Q2018-05-04fiscal Q1 201834730001564590-18-010844
10-K2018-02-27fiscal FY 2017381190001564590-18-003526
10-Q2017-11-07fiscal Q3 201731780001564590-17-022271
10-Q2017-08-08fiscal Q2 201731780001564590-17-016559
10-Q2017-05-09fiscal Q1 201732640001564590-17-009889
10-K2017-02-28fiscal FY 2016401110001564590-17-002866
10-Q2016-11-07fiscal Q3 201633760001564590-16-027956
10-Q2016-08-04fiscal Q2 201633750001564590-16-022733
10-Q2016-05-05fiscal Q1 201627570001564590-16-017989
10-K2016-02-29fiscal FY 201533990001193125-16-483533
10-Q2015-11-05fiscal Q3 201527710001193125-15-368368
10-Q2015-08-06fiscal Q2 201526690001193125-15-281018
10-Q2015-05-07fiscal Q1 201526550001193125-15-177138
10-K2015-02-26fiscal FY 201429900001193125-15-066078
10-Q2014-11-10fiscal Q3 201426690001193125-14-406106
10-Q2014-08-05fiscal Q2 201426690001193125-14-295781
10-Q2014-05-06fiscal Q1 201426530001193125-14-184864
10-K2014-02-27fiscal FY 201329900001193125-14-073040
10-Q2013-11-06fiscal Q3 201327710001193125-13-430089
10-Q2013-08-06fiscal Q2 201324660001193125-13-321550
10-Q2013-05-07fiscal Q1 201326540001193125-13-204467
10-K2013-03-12fiscal FY 2012361110001193125-13-103111
10-Q2012-11-05fiscal Q3 201229780001193125-12-451812
10-Q2012-08-08fiscal Q2 201229770001193125-12-344007
10-Q2012-05-08fiscal Q1 201229600001193125-12-218369
10-K2012-03-06fiscal FY 201133860001193125-12-098990
10-Q2011-11-09fiscal Q3 201129720001193125-11-304578
10-Q2011-08-10fiscal Q2 201129720001193125-11-218116

Inspect the source

Entity
ACADIA PHARMACEUTICALS INC. / CIK 0001070494
Captured
2026-09-20T05:19:37.996Z
SEC response SHA-256
b715477790e2bc4da8926097c8339e6eadd0d719aa545289c22b84a7adf5e2d1

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001070494.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))